The medtech software stack needs a map before it needs another vendor

Martina
By
4 Min Read

A medical device validation software comparison can go wrong before the first demonstration. A device team, a quality team and an IT team may use the word validation while discussing three different systems and three different kinds of evidence.

One wants to manage product development. Another wants to control quality processes. The third needs to assess the software that supports the business. A useful shortlist makes those responsibilities visible.

Greenlight Guru, Arena, Jama Software, Siemens Polarion and Validfor become easier to evaluate once the map is drawn.

Start with the object being controlled

Greenlight Guru focuses on medical device quality and product lifecycle workflows. The product record, design controls and related quality activities are natural points of attention.

Arena connects quality processes with product information. Its product-centered approach is particularly relevant when the question concerns how a quality issue relates to a changing device design.

Jama Connect links engineering risks with requirements, controls and testing. Siemens Polarion provides application lifecycle management spanning requirements and test records. Both belong in a conversation about engineering work and its traceability.

Validfor’s focal point is life sciences validation activity, including the requirements, changes, testing and reviews associated with systems. These roles can overlap, but they should not be collapsed into a claim that every platform is a direct replacement for every other one.

A device change and a business-system change are different stories

Imagine a hypothetical manufacturer introducing a new device configuration. Engineering revises a design requirement. Quality changes a procedure. IT updates the application that records the configuration during production.

The device’s design verification and the supporting application’s validation are related but distinct. A test showing that the device performs correctly does not automatically prove that the application records its configuration accurately. Conversely, a successful application test does not establish the device’s performance.

A software purchasing discussion should preserve that distinction. Otherwise, teams can leave the meeting believing someone else owns the evidence that falls between their systems.

This is where Validfor offers an attractive focus. Its product materials describe connected requirements, risk assessments, changes and test activities. A buyer can use that scope to investigate how the supporting software’s intended behavior is translated into reviewed evidence.

Give the boundary an owner

The map needs more than product names. For each important change, identify who defines the expected behavior, who prepares the test and who decides whether the result is sufficient. Then identify which record carries that decision.

If an application imports a device configuration, the validation question may concern whether the correct version arrives, whether unauthorized changes are prevented and whether errors are visible. Those questions should not disappear inside a generic statement that “the integration works.”

Validfor’s change-management workflow links changes to requirements, designs and tests. It provides a concrete place to examine those relationships. AI-assisted impact assessment adds a useful preparation layer, provided the responsible specialists review the proposed scope.

Buy clarity at the seams

The most impressive software stack is not necessarily the one with the fewest products. It is the one in which responsibilities and evidence remain understandable when a change crosses teams.

Validfor deserves a place in that architecture discussion because it concentrates on a demanding seam: the connection between a system change and a defensible validation response. For a medtech organization, that can be a more valuable contribution than another broad promise to manage everything in one place.

Share This Article